期刊文献+

腹膜透析感染期过氧化物酶体增殖物激活受体γ水平的变化及意义 被引量:1

Effect of dialysis-induced peritonitis on peroxisome proliferator-activated receptor γ mRNA experession of peritoneal monocyte in peritoneal dialysis patients
下载PDF
导出
摘要 目的探讨腹膜透析感染期过氧化物酶体增殖物激活受体γ水平的变化及意义。方法选择哈尔滨医科大学附属第一医院肾内科腹膜透析患者,分为实验组与对照组,应用RT-PCR对实验组和对照组腹膜透析液及外周抗凝血提取的巨噬细胞PPARγmRNA表达水平进行测定,ELISA测定外周血单核细胞TNF-α、IL-6水平。结果RT-PCR显示腹膜透析液及外周血单核细胞PPARγmRNA的表达水平,实验组第1天[分别为(0.52±0.06),(0.68±0.07)]均明显低于实验组第5天[分别为(0.66±0.09),(0.89±0.08)及对照组[分别为(0.68±0.08),(0.93±0.06)](P<0.01)。腹膜炎症初期,PPARγmRNA为低表达。ELISA测定外周抗凝血单核细胞TNF-α、IL-6水平,实验组第1天[分别为(20.16±11.26)ng/L,(26.89±13.46)ng/L]均明显高于实验组第5天[分别为(6.38±4.28)ng/L,(8.96±4.67)ng/L]及对照组[分别为(5.39±3.50)ng/L,(7.83±4.26)ng/L](P<0.01),与PPARγmRNA表达水平呈明显负相关。结论腹膜透析合并腹膜炎初期患者腹腔巨噬细胞PPARγmRNA低表达,PPARγ在腹腔局部免疫中可能有重要意义。 Objective To investigate the effect of dialysis-induced peritonitis onperoxisome proliferator-activated receptor(PPAR)-γ mRNA expression of peritoneal monocyte in peritoneal dialysis patients.Methods Thirty-nine peritoneal dialysis patients were divided into experimental group(EG, n=19) and control group (CG, n=20), The PPAR-γ gene expression of peripheral blood(PB) monocyte and peritoneal dialysis effluent (PDE) was examined by RT-PCR. The TNF- α and IL-6 concentrations of peripheral blood monocyte were estimated by ELISA. Results The PPAR- mRNA expression of peripheral blood monocyte and PDE onocyte on day 1 of EG (0. 52±0.06 and 0. 68±0. 07) respectively was significantly lower than that of CG (0.68±0.08 and 0.93±0.06) respectively that of EG and on day 5 (0.66±0.09 and 0. 89±0.08 respectively). The TNF-a and IL-6 concentrations of peripheral blood monocyte on day 1 of EG [(20. 16 ± 11. 26)ng/L and (26. 89±13. 46)ng/L respectively] were significantly higher than that of CG [(6. 38±4. 28)ng/L and (8. 96 ±4. 67) ng/L respectively] and day 5 of EG [(5. 39 ± 3. 50)ng/L and (7. 83 ± 4. 26)ng/L respectively]. A significant negative correlation were observed between TNF- α and IL-6 concentration and PP γ mRNA expression. Conclusion The expression was significantly low at the initial stage of peritonitis in peritoneal dialysis patients. These data indicate that the PPAR γ might be involved in the defense mechanism of the Peritoneum.
出处 《中国血液净化》 2006年第12期822-825,共4页 Chinese Journal of Blood Purification
关键词 腹膜透析 腹膜炎 PPAR γ Peritoneal dialysis Peritonitis: Peroxisorne proliferator-activatedreceptor-γ
  • 相关文献

参考文献15

  • 1刘伏友,李军.实验性腹膜炎时细胞、溶质和水的转运[J].湖南医科大学学报,1996,21(6):479-482. 被引量:6
  • 2Betjes MG, TukCW, Struijk DG, et al. Immuno-effector characteristics of peritoneal cells during CAPD treatment: A longitudinal study. Kidney Int, 1993, 43:641-648.
  • 3Dalei Shao, Sham inaM, Rangwala, et al. Interdomain communication regulating ligand binding by PPAR γ.Nature, 1998,396 (26): 377.
  • 4Jorres A, Jorres D, Gahl GM, et al. Leuk/triene B4 and tumor necrosis foctor release from leukocytes: Effect of peritoneal dialysis. Nephron, 1991,58:276-281.
  • 5Goldstein CS, bomalski J S, Zurier RB. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int, 1984,26:733-740.
  • 6Suassuna JH, Das Neves FC, Hartley RB, et al. Imunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD.Kidney Int, 1994,46:443-454.
  • 7王伟铭,陈楠.过氧化物酶体增生物激活受体与肾脏疾病[J].肾脏病与透析肾移植杂志,2003,12(1):70-72. 被引量:3
  • 8Kliewer SA, Umesono K, Noonan DJ, et al. Convergence of 9-cisretinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors.Nature, 1992, 358:771-774.
  • 9Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature, 1998, 391:79-82.
  • 10Jiang C, Ting A T, Seed B. PPAR γ agonists inhibit production of monocyte inflammatory cytokines[J]. Nature, 1998, 391:82-86.

二级参考文献20

  • 1Guan Y, Breyer MD. Peroxisome proliferator-activated receptors(PPARs):Novel therapeutic targets in renal disease. Kidney Int,2001,60:14
  • 2Yang T, Michele DE, Park J et al. Expression of Peroxisome proliferatoractivated receptors and retinoid X receptors in the kidney. Am J Physiol,1999,277: F966
  • 3Jiang C, Ting AT, Seed B. PPAR γ agonists inhibit production of monocyte inflannatory cytokines. Nature, 1998,391: 82
  • 4Djonadi F, Bastin J. PPARa gene expression in the developing rat kidney:Role of glucocorticoids. J Am Soc Nephrol,2002,12:1 197
  • 5Ouali F, Djonadi F, Merlet-Benichou C et al. Dietary lipids regulate β-oxidation enzyme gene expression in the developing rat kidney. J Am Physiol, 1998,275: F777
  • 6Makino H,Kashihara N,Sugiyama H et al. Phenotypic modulation of the mesangium reflected by contractile protein in diabetes. Diabetes, 1995,45:488
  • 7Johnson Rj, Iida H, Alpers CE et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. a-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest,1991,87:847
  • 8Reilly CM, Oates JC, Cook JA et al. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-γ agonists. J Immunol, 2000,278:1 498
  • 9Asano T, Wakisaka M, Yoshinari M et al. Peroxisome proliferator-activated receptors gamma 1 (PPAR gamma 1 ) exporesses in rat mesangial cells and PPAR gamma agonists modulate its differentiation. Biochem Biophys Acta,2000,1 497:148
  • 10Weston WM, Heise MA,Porter LE et al. Rosiglitazone-medidiated reductions in urinary albumin excretion are associated with changes in ambulatory blood pressure in Type 2 Diabetes patients(abstract). Diabetes,2001,50(Suppl 2): A134

共引文献7

同被引文献16

  • 1窦献蕊,余学清,郝文科,聂静,李晓艳,陈文芳,王欣,贾占军.上调Smad7表达对大鼠腹膜纤维化模型腹膜间皮细胞转分化的影响[J].中华肾脏病杂志,2006,22(10):612-616. 被引量:9
  • 2钱家麒,林爱武.提高腹膜透析患者生存率系列研究[J].医学研究杂志,2007,36(3):52-52. 被引量:2
  • 3Sandoval P, Loureiro J, Gonzdlez-Mateo G, et al. PPAR-7 agonist rosiglitazone protects peritoneal membrane from dialysis fluid-in- duced damage. Lab Invest,2010,90: 1517-1532.
  • 4Liu YH, Liu FY, Zhang H. Effect of High Glucose on the Cell Proliferation. Damage and Cytokine in Human Peritoneal Meso- thelial Cells. Medical Journal Zhergnan University, 2006,31:575- 579.
  • 5Kihm LP,Wibisono D, Muller KS, et al. RAGE expression in the human peritoneal membrane. Nephrol Dial Transplant, 2008,23 : 3302-3306.
  • 6Peng Y, Liu H, Liu F, et al. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells. Nephrology (Carlton), 2006, 11 : 516-523.
  • 7Song SH,Kwak IS, Yang BY, et al. Role of rosiglitazone in li- popolysaccharide-induced peritonitis: A rat peritoneal dialysis model. Nephrology(Carlton), 2009,14:155-163.
  • 8Zhao ZZ, Cao Y, Liu ZS, et al. Effects of recombinant human en- dostatin on peritoneal angiogenesis in peritoneal dialysis rats. Nephrology(Carlton), 2011,16 : 599-606.
  • 9Shahin D, Toraby EE, Abdel-Malek H, et al. Effect of peroxi- some proliferator-activated receptor gamma agonist (pioglita- zone) and methotrexate on disease activity in rheumatoid arthritis (experimental and clinical study). Clin Med Insights Arthritis Musculoskelet Disord,2011,4:1-10.
  • 10龚立峰.细胞因子在腹膜透析腹膜纤维化中的作用[J].井冈山医专学报,2008,15(2):3-5. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部